CADUCEUS CAPITAL II, L.P.
Profile
Company Names
CADUCEUS CAPITAL II, L.P.
ORBIMED PARTNERS II, L.P.
Addresses
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY 10022
767 THIRD AVENUE, 30TH FLOOR, NEW YORK, NY 10017
Phone Numbers
212-739-6400
Entity Type:
LIMITED PARTNERSHIP
Industry:
HEDGE FUND
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$1,779,469,650.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
1998-06-01
$1,779,469,650.00
INDEFINITE
INDEFINITE
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
BONITA
EXECUTIVE OFFICER
VIEWRAY INC
| ENOBIA PHARMA CORP
| LOXO ONCOLOGY, INC.
| TRICIDA, INC.
| VIEWRAY, INC.
| ACUTUS MEDICAL, INC.
| SI-BONE, INC.
| PRELUDE THERAPEUTICS INC.
| PRELUDE THERAPEUTICS INC
| IMARA INC.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| TREELINE BIOSCIENCES, INC.
| IKENA ONCOLOGY, INC.
| ADELA, INC.
| THROMBOLEX, INC.
SVEN
H.
BORHO
EXECUTIVE OFFICER, PROMOTER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED PARTNERS, LTD.
| ORBIMED GLOBAL HEALTHCARE FUND, LTD.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, LTD.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED GENESIS FUND, LTD.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
CARL
L.
GORDON
EXECUTIVE OFFICER, PROMOTER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| AMARIN CORP PLC\UK
| SELECTA BIOSCIENCES INC
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP
| ACCELERON PHARMA INC
| SINGULEX INC
| SINGULEX, INC.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| COMPASS THERAPEUTICS, INC.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
GEOFFREY
C.
HSU
EXECUTIVE OFFICER, PROMOTER
CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
SAMUEL
D.
ISALY
EXECUTIVE OFFICER, PROMOTER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, LTD.
| CADUCEUS CAPITAL, L.P.
| ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, LTD.
| ORBIMED PARTNERS, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, LTD.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| EMERGING MARKETS HEALTHCARE PARTNERS INTERNATIONAL LTD.
| WORLDWIDE HEALTHCARE PARTNERS INTERNATIONAL LTD.
| EMERGING MARKETS HEALTHCARE PARTNERS LLC
| WORLDWIDE HEALTHCARE PARTNERS LLC
SAMUEL
DAVID
ISALY
EXECUTIVE OFFICER
W.
CARTER
NEILD
EXECUTIVE OFFICER, PROMOTER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
-
ORBIMED ADVISORS LLC
EXECUTIVE OFFICER, PROMOTER
CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, LTD.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, LTD.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED GENESIS FUND, LTD.
MATTHEW
S.
RIZZO
EXECUTIVE OFFICER
MICHAEL
B.
SHEFFERY
EXECUTIVE OFFICER, PROMOTER
JONATHAN
T.
SILVERSTEIN
EXECUTIVE OFFICER, PROMOTER
CADUCEUS PRIVATE INVESTMENTS IV, LP
| GLAUKOS CORP
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP
| INTERCEPT PHARMACEUTICALS INC
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ASIA PARTNERS IV, L.P.
C.
SCOTLAND
STEVENS
EXECUTIVE OFFICER
ORBIMED PARTNERS II, L.P.
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
PETER
A.
THOMPSON
EXECUTIVE OFFICER
RESPONSE BIOMEDICAL CORP
| SILVERBACK THERAPEUTICS, INC.
| DECIBEL THERAPEUTICS, INC.
| RECODE THERAPEUTICS, INC.
| ORBIMED NEW HORIZONS FUND, L.P.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GENESIS FUND, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JP MORGAN SECURITIES
NONE
